EP1833844A4 - Signal peptides, nucleic acid molecules and methods of treatment - Google Patents

Signal peptides, nucleic acid molecules and methods of treatment

Info

Publication number
EP1833844A4
EP1833844A4 EP05814632A EP05814632A EP1833844A4 EP 1833844 A4 EP1833844 A4 EP 1833844A4 EP 05814632 A EP05814632 A EP 05814632A EP 05814632 A EP05814632 A EP 05814632A EP 1833844 A4 EP1833844 A4 EP 1833844A4
Authority
EP
European Patent Office
Prior art keywords
treatment
methods
nucleic acid
acid molecules
signal peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05814632A
Other languages
German (de)
French (fr)
Other versions
EP1833844A1 (en
Inventor
Yi-Chen Cathy Huang
Celine Levesque
Dennis G Cvitkovitch
Srinivasa Madhyastha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kane Biotech Inc
Original Assignee
Kane Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kane Biotech Inc filed Critical Kane Biotech Inc
Publication of EP1833844A1 publication Critical patent/EP1833844A1/en
Publication of EP1833844A4 publication Critical patent/EP1833844A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP05814632A 2004-12-06 2005-12-06 Signal peptides, nucleic acid molecules and methods of treatment Withdrawn EP1833844A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63373404P 2004-12-06 2004-12-06
US70752205P 2005-08-12 2005-08-12
PCT/CA2005/001845 WO2006060903A1 (en) 2004-12-06 2005-12-06 Signal peptides, nucleic acid molecules and methods of treatment

Publications (2)

Publication Number Publication Date
EP1833844A1 EP1833844A1 (en) 2007-09-19
EP1833844A4 true EP1833844A4 (en) 2009-05-13

Family

ID=36577630

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05814632A Withdrawn EP1833844A4 (en) 2004-12-06 2005-12-06 Signal peptides, nucleic acid molecules and methods of treatment

Country Status (6)

Country Link
EP (1) EP1833844A4 (en)
JP (1) JP4932731B2 (en)
AU (1) AU2005313797A1 (en)
CA (1) CA2630088A1 (en)
NZ (1) NZ556114A (en)
WO (1) WO2006060903A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007053945A1 (en) * 2005-11-09 2007-05-18 Kane Biotech Inc. Oral anti-microbial composition comprising competence-stimulating peptide
GB0608966D0 (en) * 2006-05-05 2006-06-14 Norwegian University Of Life S Method and product
AU2007292221B2 (en) 2006-09-06 2013-08-29 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof
GB0618612D0 (en) * 2006-09-21 2006-11-01 Smith & Nephew Medical device
EP2248823A1 (en) * 2009-04-28 2010-11-10 Institut National de la Recherche Agronomique New competence stimulating peptide
WO2012159216A1 (en) * 2011-05-25 2012-11-29 Kane Biotech Inc. Bone tissue regenerating peptides
WO2014033314A1 (en) 2012-09-03 2014-03-06 Uab Bioseka Antisense oligonucleotide targeting bacterial glucosyltransferases
LT6214B (en) * 2013-10-07 2015-08-25 Uab "Bioseka" Antisense oligonucleotide for prevention of atherosclerosis and cardivascular infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2332733C (en) * 2000-04-10 2012-10-02 Dennis G. Cvitkovitch Signal peptides, nucleic acid molecules and methods for treatment of caries
US6923962B2 (en) * 2000-04-10 2005-08-02 Dennis Cvitkovitch Signal peptides, nucleic acid molecules and methods for treatment of caries
US7087228B2 (en) * 2002-07-03 2006-08-08 University Of Southern California Preventing tooth decay and infective endocarditis using natural oligopeptides
US7625554B2 (en) * 2002-09-05 2009-12-01 Brod Staley A Treatment of alzheimer's disease

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CVITKOVITCH DENNIS G ET AL: "Quorum sensing and biofilm formation in Streptococcal infections.", THE JOURNAL OF CLINICAL INVESTIGATION DEC 2003, vol. 112, no. 11, December 2003 (2003-12-01), pages 1626 - 1632, XP002522406, ISSN: 0021-9738 *
See also references of WO2006060903A1 *
SUNTHARALINGAM P ET AL: "Quorum sensing in streptococcal biofilm formation", TRENDS IN MICROBIOLOGY, ELSEVIER SCIENCE LTD., KIDLINGTON, GB, vol. 13, no. 1, 7 December 2004 (2004-12-07), pages 3 - 6, XP004705444, ISSN: 0966-842X *
VATS NEERAJ ET AL: "Active detachment of Streptococcus mutans cells adhered to epon-hydroxylapatite surfaces coated with salivary proteins in vitro", ARCHIVES OF ORAL BIOLOGY, vol. 45, no. 4, April 2000 (2000-04-01), pages 305 - 314, XP002522407, ISSN: 0003-9969 *

Also Published As

Publication number Publication date
JP4932731B2 (en) 2012-05-16
EP1833844A1 (en) 2007-09-19
AU2005313797A1 (en) 2006-06-15
AU2005313797A2 (en) 2006-06-15
WO2006060903A1 (en) 2006-06-15
NZ556114A (en) 2010-02-26
CA2630088A1 (en) 2006-06-15
JP2008522985A (en) 2008-07-03

Similar Documents

Publication Publication Date Title
EP1664298A4 (en) Modified gene-silencing nucleic acid molecules and uses thereof
IL181779A (en) Class of therapeutic protein based molecules
PL1751278T3 (en) Nicotiana nucleic acid molecules and uses thereof
GB2413796B (en) Methods and means for nucleic acid sequencing
IL179227A0 (en) Methods and reagents for the treatment of immunoinflammatory disorders
EP2037737A4 (en) Proteins, nucleic acids encoding the same and associated methods of use
WO2005079363A3 (en) Aptamer therapeutics useful in the treatment of complement-related disorders
EP1833844A4 (en) Signal peptides, nucleic acid molecules and methods of treatment
IL174918A0 (en) Methods and reagents for the treatment of immunoinflammatory disorders
IL174185A0 (en) Methods and reagents for the treatment of immunoinflammatory disorders
GB0514909D0 (en) Methods of nucleic acid amplification and sequencing
WO2006088888A3 (en) Aptamer therapeutics useful in the treatment of complement-related disorders
TWI367326B (en) Wnt proteins and detection and treatment of cancer
EP1805519A4 (en) Wnt proteins and detection and treatment of cancer
EP2086576A4 (en) Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
AU2003216184A8 (en) Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof
EP1627046A4 (en) Domain-exchanged binding molecules, methods of use and methods of production
EP1731610A4 (en) Proteins imparting boron-tolerance and genes thereof
EP1937717A4 (en) Penumbra nucleic acid molecules, proteins and uses thereof
DE602005023466D1 (en) ASYMMETRIC L-AMINO ACID AMID HYDROLASE AND DNA CODING THEREOF
EP1390486A4 (en) Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
HK1104042A1 (en) Nicotiana nucleic acid molecules and uses thereof
EP1904648A4 (en) Method for localization of nucleic acid associated molecules and modifications
AU2003222241A8 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2003241361A8 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070706

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: CVITKOVITCH, DENNIS, G.

Inventor name: MADHYASTHA, SRINIVASA

Inventor name: HUANG, YI-CHEN, CATHY

Inventor name: LEVESQUE, CELINE

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090417

17Q First examination report despatched

Effective date: 20090813

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120727